Bakri Y, Berkowitz R S, Goldstein D P, Subhi J, Senoussi M, von Sinner W, Jabbar F A
King Faisal Gestational Trophoblastic Center, Section of Gynecologic Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
J Reprod Med. 1994 Mar;39(3):179-84.
Brain involvement by gestational trophoblastic tumor (GTT) was diagnosed by computed tomography in 23 (17%) of 131 patients with metastatic GTT at King Faisal Specialist Hospital and Research Centre between January 1980 and December 1990. All 23 patients had concurrent lung involvement, and 20 presented with neurologic symptoms. There were three treatment groups: Group A--methotrexate, actinomycin-D, chlorambucil and brain irradiation; group B--cisplatin, VP-16, actinomycin-D and intrathecal methotrexate; and group C--palliative therapy and other chemotherapy. While no patients in groups A or C survived, 4 (57%) of 7 patients in group B achieved complete, sustained remission. Serum:cerebrospinal fluid beta-human chorionic gonadotropin ratios were measured in 9 patients and were < 60 in only 4 patients. The clinical features of patients with brain metastases are reviewed in detail.
1980年1月至1990年12月期间,在费萨尔国王专科医院和研究中心,131例转移性妊娠滋养细胞肿瘤(GTT)患者中,23例(17%)经计算机断层扫描诊断为脑转移。所有23例患者均同时伴有肺部转移,20例出现神经症状。有三个治疗组:A组——甲氨蝶呤、放线菌素-D、苯丁酸氮芥及脑部放疗;B组——顺铂、依托泊苷、放线菌素-D及鞘内注射甲氨蝶呤;C组——姑息治疗及其他化疗。A组和C组无患者存活,而B组7例患者中有4例(57%)实现了完全、持续缓解。对9例患者测定了血清:脑脊液β-人绒毛膜促性腺激素比值,仅4例患者该比值<60。本文详细回顾了脑转移患者的临床特征。